Treatment of tumor‐induced cardiovascular dysfunction with losartan, an angiotensin II receptor antagonist

Autor:	Sarah C. W. Stevens, Dane J. Youtz, Yvonne Clark, Sabahattin Bicer, Loren E. Wold, Raymond D. Devine
Rok vydání:	2013
Předmět:	Angiotensin receptor Losartan Angiotensin II receptor type 1 business.industry Genetics medicine Angiotensin II receptor antagonist Pharmacology business Molecular Biology Biochemistry Biotechnology medicine.drug
Zdroj:	The FASEB Journal. 27
ISSN:	1530-6860 0892-6638
DOI:	10.1096/fasebj.27.1_supplement.1197.8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f32660abbe77f4eb560044f50a714166 https://doi.org/10.1096/fasebj.27.1_supplement.1197.8 Zobrazit plný text záznamu Plný text